Not all newer technologies are more effective than current incumbent technologies. Just because they are new do not mean they are more effective.
Within the past decade, there have been many new technologies that have been approved for use.
While the diagnostic modalities have proven to be useful because their approval comes with the support of clinicians using them as proof of their effectiveness, this is not necessarily so for all the newer medical technologies approved for therapeutic use which may be associated with conflicts of interest.
While numerous newer medical technologies are emerging, some may not significantly improve upon existing treatments in terms of effectiveness.
These technologies might offer convenience at higher costs, but their impact on patient outcomes may be minimal as compared to incumbent modalities of treatment.
Overpromising and Lack of Evidence: Some new technologies are hyped as revolutionary, but may not have strong clinical evidence supporting their effectiveness.
Primarily for Convenience: Some new technologies are primarily designed for convenience or ease of use, rather than offering substantial improvements in treatment outcomes.
Cost-Effectiveness Concerns: New technologies may come with high development, manufacturing, and implementation costs, which can raise questions about their cost-effectiveness. If the improvements in effectiveness are minimal, the high costs may not be justified.
Need for Rigorous Evaluation: It is crucial to evaluate new technologies rigorously through clinical trials and real-world studies to assess their true impact on patient outcomes. Over-promising and a lack of robust evidence can create unrealistic expectations, potentially leading to disappointment or wasted resources.
While newer surgical technologies offer promising advancements, some may not significantly improve outcomes compared to established methods, potentially leading to increased costs and complexity without demonstrable benefits.
The focus should be on technologies that genuinely enhance surgical precision, minimize invasiveness, improve patient outcomes, and are justified by robust clinical evidence.
The problems with newer innovative surgical techniques include:
Adopting New Technologies Without Strong Evidence
Surgical innovations that lack robust clinical trials and fail to demonstrate superiority over existing procedures can waste resources and potentially put patients at risk.
Surgeons and patients may be drawn to the promise of new technologies even with limited evidence of their effectiveness, leading to early adoption before sufficient data is available.
Lack of transparency in claims–it is crucial to be wary of claims that a new technology offers dramatic improvements without rigorous testing and comparison to established techniques.
Minimally Invasive Surgery And Robotics
Focus on Precision and Reduced Invasiveness: While minimally invasive surgery (MIS) and robotics offer potential benefits like smaller incisions, faster recovery times, and reduced pain, the effectiveness can vary depending on the procedure and the surgeon’s experience.
Not Always Superior: In some cases, traditional open surgery may be preferred for certain conditions, particularly if the new technology adds unnecessary complexity without a clear advantage.
Robotics and AI: Robots and AI can assist surgeons in complex procedures, but they are not a replacement for human expertise and may not offer a significant advantage in all situations. They are primarily designed for convenience or ease of use, rather than offering substantial improvements in treatment outcomes.
Importance Of Robust Clinical Trials
Randomised Controlled Trials (RCTs) Are Crucial: These trials help to determine whether a new technology or procedure is truly superior to existing methods and if it provides measurable benefits for patients.
Real-World Data: It is important to consider real-world data and outcomes beyond initial trials to assess the long-term impact of new technologies.
Focus On Patient Outcomes And Cost-Effectiveness
Prioritise Patient Benefits: New technologies should be evaluated based on their ability to improve patient outcomes, including reduced complications, faster recovery, and enhanced quality of life.
Cost-Effectiveness: The cost of new technologies should be weighed against the benefits they offer, and alternative, more cost-effective options should be considered when possible.
In summary, while new surgical technologies hold great promise, it is essential to approach them with a critical and evidence-based perspective.
Prioritising robust clinical trials, focusing on patient outcomes, and carefully evaluating the cost-effectiveness of new technologies is crucial to ensure that they truly benefit patients without adding unnecessary risk or expense
While newer surgical technologies may offer potential benefits, some lack demonstrable improvements in effectiveness and may even present drawbacks.
Some examples of newer technologies that have not shown a significant clinical advantage include 3D printed medical devices, some uses of virtual reality, point-of-care tests for specific conditions where the benefit over established methods is marginal, certain advanced imaging techniques that are expensive and offer limited additional information compared to simpler methods, single-site and single-port laparoscopic surgery, many recent minimally invasive surgical treatments, certain robotic surgery applications, and some aspects of virtual reality surgery training.
Some technologies, while promising, might be less effective in complex or high-risk surgeries. Surgeons might adapt techniques from existing procedures rather than introducing truly innovative procedures, which can lead to a lack of rigorous evaluation and standardisation.
Dr Rajeentheran Suntheralingam is a senior consultant urologist and urological surgeon.
- This is the personal opinion of the writer or publication and does not necessarily represent the views of CodeBlue.
